Pfizer

Forecast & Rating28 analysts currently cover Pfizer, with about 35.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $28.88, about 5.0% upside from the current price of $27.50. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 22.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Pfizer's outlook. Data as of Sep 15, 2026; for reference only and not investment advice.